This press release was updated on July 28, 2022 to reflect that Cleerly secured additional Series C funding, raising its round total from $192 million to $223 million. Updated July 28, 2022: New York – July 25, 2022 — Cleerly, the company […]
Tag: Cleerly
NEW STAGING SYSTEM FOR CORONARY ARTERY DISEASE
April 20, 2022 New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque – not secondary symptoms of heart disease. Quantification of CAD burden and plaque type has demonstrated to be the […]
CLARIFY 2 AFFIRMS CLEERLY OVER INVASIVE HEART DISEASE EVALUATION METHODS
Findings from Cleerly’s groundbreaking CLARIFY 2 study echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation. The study, the second of six studies comparing Cleerly analysis against current gold standards to plaque and coronary artery […]
Cleerly Takes Precision Heart Care to the Next Level with Cleerly 2.2.0
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) […]
Cleerly Named to NYC Digital Health 100 by New York City Health Business Leaders
Organization recognizes the most promising and innovative health startups in New York NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway […]
Cleerly Expands Board of Directors with Three New Members
NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has expanded its board of directors with three new medical and investment leaders. Kevin M. King, Glenn D. Steele Jr., MD, PhD and […]
CLEERLY APPOINTS JIM HARTMAN AS CHIEF REVENUE OFFICER
Sales strategy expert brings industry success to leverage growth. NEW YORK – October 18, 2021 – Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Jim Hartman as Chief Revenue Officer. In […]
Cleerly Expands Executive Team With Appointment of New Chief Operating Officer and Chief Technology Officer
Brandon Atkinson joins as COO and Nick Nieslanik as CTO to Support Company’s Mission to Create a New Standard of Care for Heart Disease, the Leading Cause of Death. NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care […]
Canon Medical Partners with Cleerly to Tackle Heart Disease, the Leading Cause of Death
The collaboration breaks new ground by integrating Canon’s AI-powered CT technology with Cleerly’s digital pathway solution for analysis of coronary artery disease. TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems, USA joins forces with Cleerly in a strategic partnership to support simple and […]
Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease
Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address Heart Disease Using Artificial Intelligence NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, […]
Recent
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Popular
- No commented posts yet